Patient-reported tolerability and acceptability of cabotegravir + rilpivirine long-acting injections for the treatment of HIV-1 infection: 96-week results from the randomized LATTE-2 study

  1. Murray, M.
  2. Pulido, F.
  3. Mills, A.
  4. Ramgopal, M.
  5. LeBlanc, R.
  6. Jaeger, H.
  7. Canon, V.
  8. Dorey, D.
  9. Griffith, S.
  10. Mrus, J.
  11. Spreen, W.
  12. Margolis, D.
Revue:
HIV Research and Clinical Practice

ISSN: 2578-7470,  2578-7489

Année de publication: 2019

Volumen: 20

Número: 4-5

Pages: 111-122

Type: Article

DOI: 10.1080/25787489.2019.1661696 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus